.
BLRX financial statements
* Numbers in thousands
Year |
2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
Capitalization * |
47 093 | 77 079 | 65 666 | 58 381 | 52 949 | 58 952 | 98 068 | 70 587 | 22 547 | 47 029 | 26 633 |
EV * |
38 516 | 58 824 | 56 797 | 52 598 | 47 842 | 56 826 | 93 208 | 75 916 | 25 943 | 36 221 | 36 221 |
Stock price $ |
57.15 | 68.25 | 43.8 | 27 | 15.45 | 15.75 | 16.35 | 9.75 | 2.31 | 2.79 | 1.58 |
Number of shares * |
824 | 1 129 | 1 499 | 2 162 | 3 427 | 3 743 | 5 998 | 7 240 | 9 760 | 16 856 | 16 856 |
EPS |
-16,00 | -18,08 | -11,77 | -4,71 | -4,20 | -4,23 | -4,06 | -3,17 | -2,61 | -1,78 | -1,78 |
Revenue * |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income * |
-13 186 | -20 415 | -17 642 | -10 175 | -14 400 | -15 841 | -24 352 | -22 962 | -25 446 | -30 021 | -30 021 |
Operating profit * |
-15 411 | -21 830 | -17 626 | -15 850 | -16 196 | -16 513 | -25 240 | -25 605 | -28 111 | -22 927 | -22 927 |
Total liabilities * |
6 806 | 9 336 | 8 265 | 4 400 | 3 692 | 3 912 | 8 084 | 14 912 | 20 187 | 25 260 | 25 260 |
Net debt * |
-8 577 | -18 256 | -8 869 | -5 783 | -5 107 | -2 126 | -4 860 | 5 329 | 3 396 | -10 808 | -10 808 |
Total assets * |
29 338 | 24 307 | 19 948 | 36 166 | 51 302 | 38 939 | 60 965 | 56 233 | 53 567 | 47 290 | 47 290 |
Equity * |
22 532 | 14 971 | 11 683 | 31 766 | 47 610 | 35 027 | 52 881 | 41 321 | 33 380 | 22 030 | 22 030 |
Cash and investments * |
25 970 | 21 360 | 18 157 | 34 637 | 47 663 | 35 623 | 49 483 | 30 151 | 27 489 | 22 587 | 22 587 |
Over the past 10 years, the maximum capitalization of BioLineRx Ltd. is 98 068, the minimum is 22 547. Maximum net income 0, Minimum net income -30 021. The maximum price of BLRX shares is 68.25, the minimum price is 2.31.
.
BLRX valuation
Year |
2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3,57 | -3,78 | -3,72 | -5,74 | -3,68 | -3,72 | -4,03 | -3,07 | -0,89 | -1,57 | -0,89 |
P/B |
2,09 | 5,15 | 5,62 | 1,84 | 1,11 | 1,68 | 1,85 | 1,71 | 0,68 | 2,13 | 1,21 |
P/S |
0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
E/P |
-28% | -26% | -27% | -17% | -27% | -27% | -25% | -33% | -113% | -64% | -113% |
P/FCF |
-4,09 | -3,80 | -3,23 | -3,98 | -3,14 | -4,05 | -3,96 | -2,05 | -0,99 | 0,00 | 0,00 |
.
BLRX profitability
Year |
2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
ROE |
-59% | -136% | -151% | -32% | -30% | -45% | -46% | -56% | -76% | -136% | |
ROA |
-45% | -85% | -90% | -28% | -28% | -41% | -45% | -67% | -80% | -63% | |
ROIC |
-68% | -122% | -104% | -48% | -34% | -47% | -47% | -52% | -68% | -63% |